United Therapeutics Corp. (UTHR)
591.17
-2.14
(-0.36%)
USD |
NASDAQ |
Nov 13, 16:00
591.11
-0.06
(-0.01%)
After-Hours: 19:59
United Therapeutics Shareholders Equity (Quarterly) : 6.276B for Sept. 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 6.276B |
| June 30, 2026 | 6.400B |
| March 31, 2026 | 5.901B |
| December 31, 2025 | 7.096B |
| September 30, 2025 | 6.590B |
| June 30, 2025 | 7.174B |
| March 31, 2025 | 6.807B |
| December 31, 2024 | 6.444B |
| September 30, 2024 | 6.101B |
| June 30, 2024 | 5.697B |
| March 31, 2024 | 5.338B |
| December 31, 2023 | 5.985B |
| September 30, 2023 | 5.712B |
| June 30, 2023 | 5.411B |
| March 31, 2023 | 5.123B |
| December 31, 2022 | 4.797B |
| September 30, 2022 | 4.562B |
| June 30, 2022 | 4.318B |
| March 31, 2022 | 4.176B |
| December 31, 2021 | 3.959B |
| September 30, 2021 | 3.830B |
| June 30, 2021 | 3.640B |
| March 31, 2021 | 3.445B |
| December 31, 2020 | 3.395B |
| September 30, 2020 | 3.283B |
| Date | Value |
|---|---|
| June 30, 2020 | 3.094B |
| March 31, 2020 | 2.948B |
| December 31, 2019 | 2.780B |
| September 30, 2019 | 2.716B |
| June 30, 2019 | 2.567B |
| March 31, 2019 | 2.338B |
| December 31, 2018 | 2.808B |
| September 30, 2018 | 2.712B |
| June 30, 2018 | 2.585B |
| March 31, 2018 | 2.389B |
| December 31, 2017 | 2.121B |
| September 30, 2017 | 2.089B |
| June 30, 2017 | 1.795B |
| March 31, 2017 | 2.076B |
| December 31, 2016 | 1.862B |
| September 30, 2016 | 1.850B |
| June 30, 2016 | 1.817B |
| March 31, 2016 | 1.723B |
| December 31, 2015 | 1.599B |
| September 30, 2015 | 1.478B |
| June 30, 2015 | 1.051B |
| March 31, 2015 | 1.103B |
| December 31, 2014 | 1.253B |
| September 30, 2014 | 1.191B |
| June 30, 2014 | 1.185B |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Liquidia Corp. | -25.43M |
| Alnylam Pharmaceuticals, Inc. | 3.604B |
| Exelixis, Inc. | 1.834B |
| Gilead Sciences, Inc. | 13.04B |
| Insmed, Inc. | 726.21M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 7.034B |
| Total Liabilities (Quarterly) | 758.10M |
| Current Ratio | 4.614 |